Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes

Knud Esser1, Xiaoming Cheng1, Jochen M. Wettengel1, Julie Lucifora2,3, Lea Hansen-Palmus1, Katharina Austen1, Armando A. Roca Suarez3, Sarah Heintz3, Barbara Testoni3, Firat Nebioglu4, Minh Tu Pham4, Shangqing Yang4, Alma Zernecke5, Dirk Wohlleber6,7, Marc Ringelhan7,8, Mathias Broxtermann1, Daniel Hartmann9, Norbert Hüser9, Julia Mergner10, Andreas Pichlmair1,7,10
1Institute of Virology, Technical University of Munich, School of Medicine / Helmholtz Munich, Munich, Germany
2INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, and University of Lyon, Université Claude-Bernard (UCBL), Lyon, France
3CIRI—Centre International de Recherche en Infectiologie, Inserm, U1111, University of Lyon, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS Lyon, France
4Heidelberg University, Medical Faculty Heidelberg, Department of Infectious Diseases, Molecular Virology, Center for Integrative Infectious Diseases Research, Heidelberg, Germany
5Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany
6Institute of Molecular Immunology and Experimental Oncology, University Hospital rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany
7German Center for Infection Research (DZIF), Munich and Heidelberg partner sites, Munich and Heidelberg, Germany
82nd Medical Department, University Hospital rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany
9Department of Surgery, University Hospital rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany
10Bavarian Center for Biomolecular Mass Spectrometry at Klinikum rechts der Isar (BayBioMS@MRI), TUM, Munich, Germany